| January 12, 2016 |
 | Diclofenac, a common painkiller, has significant anti-cancer properties, researchers from the Repurposing Drugs in Oncology (ReDO) project have found. ReDO, an international collaboration between the Belgium-based Anticancer Fund and the U.S.- based GlobalCures, has published their investigation into diclofenac in the open-access journal ecancermedicalscience. Diclofenac is a well-known non-steroidal anti-inflammatory drug (NSAID) widely used to treat pain … more… |
No comments:
Post a Comment